An initial clinical study on the efficacy of cisplatin-releasing gelatin microspheres for metastatic liver tumors

European Journal of Radiology

Volumn 71, Issue 3, 2009, Pages 519-526

  Nitta, Norihisa ^a   Ohta, Shinichi ^a   Tanaka, Toyohiko ^a   Takazakura, Ryutaro ^a   Toyama, Tetsuya ^a   Sonoda, Akinaga ^a   Seko, Ayumi ^a   Furukawa, Akira ^a   Takahashi, Masashi ^a   Murata, Kiyoshi ^a   Kurumi, Yoshimasa ^a   Tani, Toru ^a   Sakamoto, Tsutomu ^b   Tabata, Yasuhiko ^c  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Kohka Public Hospital   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Chemoembolization; Delivery system; Drug; Gelatin microsphere; Intra arterial chemotherapy; Liver metastasis

Indexed keywords

CHEMOEMBOLIZATION; DELIVERY SYSTEM; DRUG; GELATIN MICROSPHERE; INTRA-ARTERIAL CHEMOTHERAPY; LIVER METASTASIS;

CHEMOTHERAPY; ENZYME INHIBITION; MICROSPHERES; ONCOLOGY; PATHOLOGY; PLATINUM COMPOUNDS; TUMORS;

LIVER;

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; EPIRUBICIN; ETOPOSIDE; GELATIN; GELFOAM; GEMCITABINE; IODINATED POPPYSEED OIL; IRINOTECAN; MICROSPHERE; MITOMYCIN C; NEDAPLATIN; TEGAFUR GIMERACIL OTERACIL POTASSIUM; TS 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT INJURY; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SIZE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FEVER; GLUCAGONOMA; HEPATIC ARTERY; HUMAN; INSULINOMA; KIDNEY DISEASE; KIDNEY DYSFUNCTION; LIVER ABSCESS; LIVER METASTASIS; LIVER NECROSIS; LIVER TUMOR; LUNG CANCER; MALE; NAUSEA AND VOMITING; PAIN; PANCREAS CANCER; PRIORITY JOURNAL; SIDE EFFECT; STOMACH CANCER; THERAPY EFFECT; THYMUS CANCER; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CISPLATIN; DELAYED-ACTION PREPARATIONS; FEMALE; GELATIN; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 69849095125     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.06.006     Document Type: Article

References (20)

1. Lorenz M., and Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 18 (2000) 243-254
2. Allen-Mersh T.G., Earlam S., Fordy C., Abrams K., and Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344 (1994) 1255-1260
3. Roche A., Girish B.V., de Baere T., et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 13 (2003) 136-140
4. Arai Y., Endo T., Sone Y., et al. Management of patients with unresectable liver metastasis from colorectal and gastric cancer employing an implantable port system. Cancer Chemother Pharmacol 31 Suppl. (1992) S99-S102
5. Arai Y., Inaba Y., and Takeuchi Y. Interventional techniques for hepatic arterial infusion chemotherapy. In: Castaneda-Zuniga W.R. (Ed). Interventional radiology (1997), Williams & Wilkins, Baltimore p. 192-205
6. Arai Y., Inaba Y., Takeuchi Y., and Ariyoshi Y. Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer. Cancer Chemother Pharmacol 40 (1997) 526-530
7. Kwon H.C., Oh S.Y., Lee S., Kim S.H., and Kim HJ. Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study. World J Gastroenterol 13 (2007) 6231-6235
8. Puthillath A., Dunn K.B., Rajput A., et al. Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer. Clin Colorectal Cancer 6 (2007) 710-715
9. Sugimoto M., Yasuda H., Koda K., et al. Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency. Hepatogastroenterology 54 (2007) 1684-1688
10. Konishi M., Tabata Y., Kariya M., et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release 103 (2005) 7-19
11. Konishi M., Tabata Y., Kariya M., et al. In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel. J Control Release 92 (2003) 301-313
12. Ohta S., Nitta N., Takahashi M., Murata K., and Tabata Y. Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model. Korean J Radiol 8 (2007) 418-428
13. Nitta N, Ohta S, Tanaka T, (in press). Gelatin microspheres: initial clinical experience for the transcatheter arterial embolization. Eur J Radiol.
14. Lewis A.L., Gonzalez M.V., Lloyd A.W., et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17 (2006) 335-342
15. Lewis A., Gonzalez M.V., Leppard S.W., et al. Doxorubicin eluting beads. 1: effects of drug loading on bead characteristics and drug distribution. J Mater Sci: Mater Med 18 (2007) 1691-1699
16. Tabata Y., Hijikata S., Muniruzzaman M., and Ikada Y. Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 10 (1999) 79-94
17. Tabata Y., Hong L., Miyamoto S., Miyao M., Hashimoto N., and Ikada Y. Bone formation at a rabbit skull defect by autologous bone marrow cells combined with gelatin microspheres containing tgf-beta1. J Biomater Sci Polym Ed 11 (2000) 891-901
18. Tabata Y., Uno K., Ikada Y., and Muramatsu S. Potentiation of antitumor activity of macrophages by recombinant interferon alpha a/d contained in gelatin microspheres. Jpn J Cancer Res 79 (1988) 636-646
19. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205-216
20. Miyayama S., Matsui O., Yamashiro M., et al. Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol 18 (2007) 365-376